Merck & Co., Inc.
MRK.PA
Get informed when a big investor buys or sells
+ FollowMarket Cap$366.59B
Close$
Share Statistics
| Market cap | $366.59 Billion |
|---|---|
| Enterprise Value | $417.87 Billion |
| Dividend Yield | $3.04 (2.34%) |
| Earnings per Share | $6.76 |
| Beta | 0.36 |
| Outstanding Shares | 2,539,614,000 |
Return
| Return on Equity | 7.57% |
|---|---|
| Return on Assets | 2.88% |
| Return on Invested Capital | 12.54% |
Valuation & Multiples
| P/E Ratio | 115.56 |
|---|---|
| PEG | -88.78 |
| Price to Sales | 3.9 |
| Price to Book Ratio | 6.34 |
| Enterprise Value to Revenue | 6.28 |
| Enterprise Value to EBIT | 40.41 |
| Enterprise Value to Net Income | 131 |
| Total Debt to Enterprise | 0.14 |
| Debt to Equity | 1.39 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Merck & Co Inc
75,000 employees
CEO: Kenneth Frazier Merck & Co., Inc. is a prominent global healthcare enterprise. It operates through two core segments: Human Pharmaceuticals and Animal Health. Its Pharmaceutical segment delivers human health products, including medications for critical ...